Scientific, Regulatory & Quality

CMC Development & Manufacturing Strategy

One team. Three functions. Zero handoffs.

Your integrated CMC team: Technical, Regulatory CMC and Quality, from preclinical to clinical to registration.

Build smarter CMC plans from the start.

Your Chemistry, Manufacturing and Controls (CMC) strategy is foundational to your program’s success. But strategy alone doesn’t get you to the clinic, execution does.

CMC360™ is Syner-G’s full-scope execution model: an embedded, cross-functional team that drives your program from concept to first-in-human and on through Phase 3 and registration. We own timelines, vendors, documentation and decisions across Technical, Regulatory CMC and Quality simultaneously.

Whether you’re building a CMC function from scratch, choosing and managing CDMOs, scaling up manufacturing or preparing for pivotal studies, we right-size our support to your stage so your program keeps moving and holds up to global scrutiny.

Why CMC360

Integrated delivery

Technical, Regulatory CMC and Quality operate as one team under a single engagement lead.

Execution, not just strategy

We own vendor timelines, author submissions and track risk in real time.

Scalable to your stage

Retainer, milestone-based or FTE models sized to fit a seed-stage biotech, a team preparing for first-in-human or a program heading to registration.

Challenges we can help solve:

0+

INDs Delivered

0+

CMC Programs

All

Modalities

US • EU

Global Reach

Trusted partner with hundreds of INDs filed.

Ready to build your path to IND or take your program through Phase 3 and registration. Let’s talk about where you are and what comes next.
Talk to an Expert

Our Approach

Strategy, science and execution, seamlessly connected.

We don’t just advise. We work hand in hand with your team to design and execute CMC strategies that keep programs on track from ground-up planning to targeted solutions, sized to your goals, timelines and budget.

  • Modalities: small molecule, biologics (mAbs, bispecifics, fusion proteins), ADCs, peptides, oligonucleotides, and cell & gene therapy
  • Lifecycle: hands-on from preclinical through IND, Phase 3, registration and post-approval
  • Regulatory: Module 3 strategy and authoring for US, EU and rest-of-world submissions, including clinical trial applications in Australia, grounded in global expectations
  • Cross‑functional: Technical, Regulatory CMC, Quality and project integration, all as one team

We can help with:

Technical / CMC

Drug substance and drug product process development

Formulation and analytical method development

CDMO selection and oversight

Tech transfer and scale-up

Process characterization and validation

Specification setting and control strategy design

Regulatory CMC

Module 3 strategy and authoring

IND / IMPD / CTA / NDA / BLA / MAA support

Briefing books and meeting prep

Health authority engagement

Comparability protocols and change management

Post-approval lifecycle support

Quality Management

Phase-appropriate QMS build

SOPs and document control

Audit readiness and execution

Vendor qualification

Sponsor batch review and release

Inspection readiness and PAI prep

Project Integration

Timeline ownership

Risk tracking and mitigation

Vendor coordination

Cross-functional alignment

Clinical supply chain management

Advanced CMC execution for programs on the path to registration.

As programs move into Phase 2 and beyond, the stakes get higher and the scope of CMC work expands. CMC360 brings the same integrated team that got you to your initial IND to scale-up, multi-site supply and registration-ready submissions with six integrated workstreams scaled to your program’s complexity and stage.

TECHNICAL / CMC

Process Validation & Scale-Up

Process characterization, design space definition and validation strategy for Phase 3 batches, bridging clinical and commercial-scale manufacturing.
PROJECT / PM

Supply Chain & CDMO Oversight

Multi-site coordination across DS, DP, packaging and testing vendors, including scope management, quality agreements and risk mitigation across your full supply network.
REGULATORY CMC

Phase 3 & NDA/BLA Module 3

Authoring and lifecycle management of CMC sections for pivotal submissions, including comparability packages, amendments and responses to agency CMC questions.
QUALITY

Inspection Readiness & PAI Prep

Mock inspections, gap assessments and document remediation that prepare your quality systems, batch records and vendor files for pre-approval inspection.
REG CMC / TECHNICAL

Comparability & Change Management

When process, site or formulation changes are unavoidable, we build the comparability strategy, execute the studies and write the regulatory justification.
STRATEGIC

Due Diligence & Partnering Support

CMC technical reviews for licensing, acquisition or partnership discussions. Expert assessment and the investor-ready narrative your deal team needs.

Built for every modality.

Deep expertise across small and large molecule programs, with a dedicated team for every modality.

Small Molecule

Oral solids, parenterals, modified release, specialty dosage forms
50+ small molecule INDs delivered

mAb / Biologics

mAbs, bispecifics, fusion proteins
25+ biologics INDs and BLA-enabling packages

Antibody-Drug Conjugate (ADC)

ADCs, targeted conjugates
20+ ADC CMC programs supported

Peptide

Synthetic, cyclic and stapled peptides
20+ peptide programs from synthesis to IND

Oligonucleotide

ASOs, siRNA, mRNA, aptamers
15+ oligonucleotide and nucleic acid programs supported

Cell & Gene Therapy

Cell therapy and gene therapy programs

We meet you where you are.

Some teams have strong internal CMC leadership. Some are still building. CMC360 flexes to fit either.

Augment: You have internal CMC leadership. We fill the gaps.

Embedded Regulatory CMC authoring alongside your team

QA oversight and audit execution

Process validation strategy and execution support

Comparability or change management packages

Inspection readiness and PAI prep

Surge capacity during peak workload periods

Lead: You need a full CMC function. We own it.

A single engagement Fractional Head of CMC coordinating all workstreams

Full Technical, Regulatory CMC, QA and PM coverage

CDMO and multi-site supply chain management

Module 3 strategy and authoring through NDA/BLA

Inspection readiness through PAI

Scalable staffing as program complexity grows

Ideal for

Emerging biotechs with no internal CMC, Regulatory or Quality function

Companies moving from science to clinical execution

Programs preparing for IND/CTA or first GMP manufacturing

Phase 2+ teams scaling toward Phase 3 and registration

Teams that need execution support, not just strategy or a single document

Engagement models

Retainer: ongoing embedded support with flexible staffing

Milestone-based: fixed fee tied to program milestones or deliverables (CDMO, IND, etc.)

FTE model: dedicated Technical, Regulatory CMC, QA and PM leads

Let's move from science to success.

Let’s Talk